David Pendarvis was appointed as ResMed’s chief administrative officer and global general counsel in May 2011. In addition to those roles, he served as interim president for ResMed’s EMEA and Japan regions from March to August 2017. He joined ResMed as global general counsel in September 2002, and has been corporate secretary since February 2003. From 2005 to 2011, he served as senior vice president of organisational development.
Before joining ResMed, David was a partner in the law firm Gray Cary Ware & Freidenrich LLP from 2000 to 2002, where he specialised in intellectual property and general business litigation. From 1986 to 2000, he was a partner at Gibson, Dunn & Crutcher LLP. From 1984 to 1986, he was a law clerk to the Hon. J. Lawrence Irving, US District Judge, Southern District of California.
David was first elected to the board of directors of WD-40 Company (NASDAQ: WDFC) in December 2017. From 2009 to 2016, he was a director on the board of Sequenom, Inc (NASDAQ: SQNM). He has also served on the board of directors of the San Diego Regional Chamber of Commerce since 2013. From 2010 until 2019, he was a director of the Corporate Directors Forum.
David holds a bachelor of arts from Rice University; a juris doctor, cum laude, from the University of Texas School of Law; a master of science in executive leadership from the University of San Diego; and a bachelor’s in political science and managerial studies from Rice University.
, Houston, TX Register
© 2020 HMG Strategy, LLC. All Rights Reserved.